Drugs for treating giardiasis

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Granados, Carlos E ^a   Reveiz, Ludovic ^b   Cuervo, Luis Gabriel ^c   Uribe, Luis G ^d   Criollo, Claudia P ^e  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Fundacion Universitaria Sanitas   (Colombia)

^c PAN AMERICAN HEALTH ORGANIZATION   (United States)

^d UNIVERSIDAD DEL ROSARIO   (Colombia)

^e UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

5 NITROIMIDAZOLE DERIVATIVE; ALBENDAZOLE; BENZIMIDAZOLE DERIVATIVE; BERBERINE; CHLOROQUINE; FEBENDAZOLE; FURAZOLIDONE; IMIDAZOLE DERIVATIVE; MEBENDAZOLE; MEPACRINE; METRONIDAZOLE; NITAZOXANIDE; ORNIDAZOLE; PAROMOMYCIN; PLACEBO; PRAZIQUANTEL; PYRVINIUM EMBONATE; SATRANIDAZOLE; SECNIDAZOLE; TINIDAZOLE; UNCLASSIFIED DRUG;

CLINICAL EVALUATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DIARRHEA; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; FECES ANALYSIS; GIARDIA LAMBLIA; GIARDIASIS; HOSPITALIZATION; HUMAN; IMMUNOFLUORESCENCE; MALABSORPTION; OUTCOME ASSESSMENT; PREVALENCE; REVIEW; RISK ASSESSMENT; SINGLE DRUG DOSE; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 70349106906     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007787     Document Type: Review

References (48)

1. American Academy of Pediatrics. Red book: Report of the Committee on Infectious Diseases. 27th Edition. Illinois: Academy of Pediatrics, 2006.
2. Abdel Fattah SM, Maklad KA, Gadallah MA. Age-related rate of seropositivity of antibody to Giardia lamblia in different age groups in Cairo. Journal of the Egyptian Society of Parasitology 1991;21(3): 707-713
3. Al-Saeed AT, Issa SH. Frequency of Giardia lamblia among children in Dohuk, northern Iraq. Eastern Mediterranean Health Journal 2006;12(5):555-561
4. Argüello-García R, Cruz-Soto M, Romero-Montoya L, Ortega-Pierres G. Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in vitro. Journal of Antimicrobial Chemotherapy 2004;54 (4):711-721 (Pubitemid 39386722)
5. Barnawi AB, Tonkal AM, Fouad MA, Al-Braiken FA. Detection of Entamoeba histolytica/dispar in stool specimens by using enzyme-linked immunosorbent assay in the population of Jeddah City, Saudi Arabia. Journal of the Egyptian Society of Parasitology 2007;37(1): 143-150
6. Brodsky RE, Spencer HC, Schultz MG.Giardiasis in American travelers to the Soviet Union. Journal of Infectious Diseases 1974;130(3): 319-323
7. Buret A. Mechanisms of epithelial dysfunction in giardiasis. Gut 2007;56(3):316-317
8. Celiksöz A, Aciöz M, Degerli S, Cinar Z, Elaldi N, Erandaç M. Effects of giardiasis on school success, weight and height indices of primary school children in Turkey. Pediatrics international 2005;47 (5):567-571 (Pubitemid 41806169)
9. Chute CG, Smith RP, Baron JA. Risk factors for endemic giardiasis. American Journal of Public Health 1987;77(5):585-587
10. Cifuentes E, Gomez M, Blumenthal U, Tellez-Rojo MM, Romieu I, Ruiz-Palacios G, et al.Risk factors for Giardia intestinalis infection in agricultural villages practicing wastewater irrigation in Mexico. American Journal of Tropical Medicine and Hygiene 2000;62(3):388-392 (Pubitemid 30774743)
11. Cifuentes E, Suárez L, Espinosa M, Juárez-Figueroa L, Martínez-Palomo A. Risk of Giardia intestinalis infection in children from an artificially recharged groundwater area in Mexico City. American Journal of Tropical Medicine and Hygiene 2004;71(1):65-70. (Pubitemid 38902646)
12. de Souza EA, da Silva-Nunes M, Malafronte Rdos S, Muniz PT, Cardoso MA, Ferreira MU. Prevalence and spatial distribution of intestinal parasitic infections in a rural Amazonian settlement, Acre State, Brazil. Cadernos de Saúde Pública 2007;23(2):427-434
13. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors), Cochrane Handbook of Systematic Reviews of Intervention. Version 5.0.0 (updated February 2008). Available from www.cochrane-handbook.org.
14. Ekdahl K, Andersson Y. Imported giardiasis: impact of international travel, immigration, and adoption. American Journal of Tropical Medicine and Hygiene 2005;72(6):825-830 (Pubitemid 41278807)
15. Escobedo AA, Cimerman S. Giardiasis: a pharmacotherapy review. Expert Opinion on Pharmacotherapy 2007;8(12):1885-1902
16. Farthing MJ, Mata L, Urrutia JJ, Kronmal RA. Natural history of Giardia infection of infants and children in rural Guatemala and its impact on physical growth. American Journal of Clinical Nutrition 1986;43(3):395-405. (Pubitemid 16097200)
17. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, et al.Spectrum of disease and relation to place of exposure among ill returned travelers. New England Journal of Medicine 2006; 354(2):119-130 (Pubitemid 43076709)
18. Fricker CR, Medema GD, Smith HV. Protozoan parasites (Cryptosporidium, Giardia, Cyclospora). Guidelines for drinking-water quality. Second Edition. Geneva: World Health Organization, 1993:70-118.
19. Garcia LS, Garcia JP Garcia LS, Garcia JP. Detection of Giardia lamblia antigens in human fecal specimens by a solid-phase qualitative immunochromatographic assay. Journal of Clinical Microbiology 2006;44(12):4587-4588
20. Garner TB, Hill DR. Treatment of giardiasis. Clinical Microbiology Reviews 2001;14(1):114-128
21. Goek LK. Update on the prevalence of malnutrition among children in Asia. Nepal Medical College Journal 2003;5(2):113-122
22. Hanevik K, Hausken T, Morken MH, Strand EA, Mørch K, Coll P, et al.Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. Journal of infection 2007;55(6):524-530 (Pubitemid 350082473)
23. Hiatt RA, Markell EK, Ng E. How many stool examinations are necessary to detect pathogenic intestinal protozoa?. American Journal of Tropical Medicine and Hygiene 1995;53(1):36-39
24. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors), Cochrane Handbook of Systematic Reviews of Intervention. Version 5.0.0 (updated February 2008). Available from www.cochranehandbook.org.
25. Hörman A, Korpela H, Sutinen J, Wedel H, Hänninen ML. Meta-analysis in assessment of the prevalence and annual incidence of Giardia spp. and Cryptosporidium spp. infections in humans in the Nordic countries. International Journal for Parasitology 2004;34(12): 1337-1346
26. Jelinek T, Löscher T. Epidemiology of giardiasis in German travelers. Journal of Travel Medicine 2000;7(2):70-73
27. Jokipii AM, Hemila M, Jokipii L. Prospective study of acquisition of Cryptosporidium, Giardia lamblia, and gastrointestinal illness. Lancet 1985;2(8453):487-489 (Pubitemid 15013935)
28. Laupland KB, Church DL. Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region. BMC Infectious Diseases 2005;16(5):72.
29. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
30. Libanore M, Bicocchi R, Rossi MR, Montanari P, Sighinolfi L, Macario F, et al.Incidence of giardiasis in adults patients with acute enteritis. Minerva Medica 1991;82(6):375-380
31. Lora-Suarez F, Marin-Vasquez C, Loango N, Gallego M, Torres E, Gonzalez MM, et al.Giardiasis in children living in post-earthquake camps from Armenia (Colombia). BMC Public Health 2002;2:5. (Pubitemid 38994290)
32. Mahmud MA, Chappell C, Hossain MM, Habib M, Dupont HL. Risk factors for development of first symptomatic Giardia infection among infants of a birth cohort in rural Egypt. American Journal of Tropical Medicine and Hygiene 1995;53(1):84-88
33. Mank TG, Zaat JO. Diagnostic advantages and therapeutic options for giardiasis. Expert Opinion on Investigational Drugs 2001;10(8): 1513-1519 (Pubitemid 32717331)
34. Miotti PG, Gilman RH, Santosham M, Ryder RW, Yolken RH. Age related rate of seropositivity and antibody to Giardia lamblia in four diverse populations. Journal of Clinical Microbiology 1986;24(6): 972-975 (Pubitemid 17193351)
35. Morgan UM, Reynoldson JA, Thompson RC. Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro. Antimicrobial Agents and Chemotherapy 1993;37(2):328-331
36. Mukhopadhyay C, Wilson G, Pradhan D, Shivananda PG. Intestinal protozoal infestation profile in persistent diarrhea in children below age 5 years in western Nepal. Southeast Asian Journal of Tropical Medicine and Public Health 2007;38(1):13-19
37. Newman RD, Moore SR, Lima AA, Nataro JP, Guerrant RL, Sears CL. A longitudinal study of Giardia lamblia infection in north-east Brazilian children. Tropical Medicine & International Health 2001;6 (8):624-634 (Pubitemid 32830482)
38. Oztürk CE, Sahin I, Yavuz T, Oztürk A, Akgünoglu M, Kaya D. Intestinal parasitic infection in children in post-disaster situations years after earthquake. Pediatrics international 2004;46(6):656-662 (Pubitemid 40096006)
39. Park SK, Kim DH, Deung YK, KimHJ, Yang EJ, Lim SJ, et al.Status of intestinal parasite infections among children in Bat Dambang, Cambodia. Korean Journal of Parasitology 2004;42(4):201-203
40. Rajeshwari K, Jaggi N, Aggarwal V, Kalra KK, Mittal SK, Baveja U. Determinants of symptomatic giardiasis in childhood. Tropical Gastroenterology 1996;17(2):70-76
41. Redlinger T, Corella-Barud V, Graham J, Galindo A, Avitia R, Cardenas V.Hyperendemic Cryptosporidiumand Giardia in households lacking municipal sewer and water on the United States-Mexico border. American Journal of Tropical Medicine and Hygiene 2002;66(6): 794-798 (Pubitemid 35001058)
42. Rendtorff RC. The experimental transmission of human intestinal protozoan parasites II. Giardia lamblia cysts given in capsules. American Journal of Hygiene 1954;59(2):209-220
43. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
44. Schunk M, Jelinek T, Wetzel K, Nothdurft HD. Detection of Giardia lamblia and Entamoeba histolytica in stool samples by two enzyme immunoassays. European Journal of Clinical Microbiology & Infectious Diseases 2001;20(6):389-391 (Pubitemid 32646360)
45. Weitzel T, Dittrich S, Möhl I, Adusu E, Jelinek T. Evaluation of seven commercial antigen detection tests for Giardia and Cryptosporidium in stool samples. Clinical Microbiology and Infection 2006;12(7): 656-659 (Pubitemid 43842486)
46. The World Bank. Country classification. www.worldbank.org/data/ countryclass/countryclass.html (accessed 16 February 2009).
47. Yoder JS, Beach MJ, Centers for Disease Control and Prevention (CDC). Giardiasis surveillance--United States, 2003-2005. MMWR Surveillance summaries 2007;56(7):11-18
48. Zaat JOM, Mank ThG, Assendelft WJJ. Drugs for treating giardiasis. Cochrane Database of Systematic Reviews 1998, Issue 3. [DOI: 10.1002/14651858.CD000217] * Indicates the major publication for the study